Lessons for COVID-19 immunity from other coronavirus infections

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · see citing works

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · see citing works

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984 · see citing works

Antibody responses to SARS-CoV-2 in patients with COVID-19

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876 · see citing works

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,631 · see citing works

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501 · see citing works

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453 · see citing works

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375 · see citing works

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061 · see citing works

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2

Shi, J., Wen, Z., Zhong, G., Yang, H., Wang, C., Huang, B., Liu, R., He, X., Shuai, L., Sun, Z., et al. (2020) · Science · doi:10.1126/science.abb7015 · Cited by 1,908 · see citing works

Identification of a new human coronavirus

van der Hoek, L., Pyrć, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Dillen, P. M. E. W., Kaandorp, J. C., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,868 · see citing works

Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals

Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853 · see citing works

Multiorgan and Renal Tropism of SARS-CoV-2

Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · see citing works

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Tan, L., Wang, Q., Zhang, D., Jinya, D., Huang, Q., Wang, Q., Wang, Q., & Miao, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0148-4 · Cited by 1,684 · see citing works

Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia

Woo, P. C. Y., Lau, S. K. P., Chu, C., Chan, K., Tsoi, H., Huang, Y. P., Wong, B. H. L., Poon, R. W., Cai, J. J., Luk, W., et al. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.884-895.2005 · Cited by 1,525 · see citing works

Development of an inactivated vaccine candidate for SARS-CoV-2

Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434 · see citing works

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works

The Severe Acute Respiratory Syndrome

Peiris, J. S. M., Yuen, K., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,377 · see citing works

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sia, S. F., Yan, L.-M., Chin, A. W. H., Fung, K., Choy, K.-T., Wong, A. Y. L., Kaewpreedee, P., Perera, R. A. P. M., Poon, L. L. M., Nicholls, J. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2342-5 · Cited by 1,303 · see citing works

Middle East respiratory syndrome

Zumla, A. I., Hui, D. S. C., & Perlman, S. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60454-8 · Cited by 1,281 · see citing works

SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways.Preprint

Sungnak, W., Huang, N., Bécavin, C., & Berg, M. (2020) · PubMed · Cited by 1,196 · see citing works

Severe acute respiratory syndrome

Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,135 · see citing works

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Bao, L., Deng, W., Huang, B., Gao, H., Liu, J., Ren, L., Wei, Q., Yu, P., Xu, Y., Qi, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2312-y · Cited by 1,126 · see citing works

Lung pathology of fatal severe acute respiratory syndrome

Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076 · see citing works

Coronavirus avian infectious bronchitis virus

Cavanagh, D. (2007) · Veterinary Research · doi:10.1051/vetres:2006055 · Cited by 1,057 · see citing works

Lethal Infection of K18- <i>hACE2</i> Mice Infected with Severe Acute Respiratory Syndrome Coronavirus

McCray, P. B., Pewe, L., Wohlford-Lenane, C., Hickey, M., Manzel, L., Shi, L., Netland, J., Jia, H. P., Halabi, C., Sigmund, C. D., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02012-06 · Cited by 1,010 · see citing works

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P. R., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K., Convalescent Plasma Study Group, Nguyen‐Van‐Tam, J. S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 985 · see citing works

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Imai, M., Iwatsuki‐Horimoto, K., Hatta, M., Loeber, S. J., Halfmann, P., Nakajima, N., Watanabe, T., Ujie, M., Takahashi, K., Ito, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009799117 · Cited by 977 · see citing works

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Rockx, B., Kuiken, T., Herfst, S., Bestebroer, T., Lamers, M. M., Oude Munnink, B. B., de Meulder, D., van Amerongen, G., van den Brand, J., Okba, N. M. A., et al. (2020) · Science · doi:10.1126/science.abb7314 · Cited by 901 · see citing works

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Kim, Y., Kim, S.-G., Kim, S.-M., Kim, E.-H., Park, S.-J., Yu, K.-M., Chang, J.-H., Kim, E. J., Lee, S., Casel, M. A. B., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.023 · Cited by 883 · see citing works

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

Yang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.027 · Cited by 872 · see citing works

Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

Liu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830 · see citing works

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816 · see citing works

Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5

Züst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B. W., Ziebuhr, J., Szretter, K. J., Baker, S. C., Barchet, W., Diamond, M. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.1979 · Cited by 811 · see citing works

The clinical pathology of severe acute respiratory syndrome (SARS): a report from China

Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H.-X., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765 · see citing works

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

Munster, V. J., Feldmann, F., Williamson, B. N., van Doremalen, N., Pérez-Pérez, L., Schulz, J., Meade-White, K., Okumura, A., Callison, J., Brumbaugh, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2324-7 · Cited by 720 · see citing works

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Williamson, B. N., Feldmann, F., Schwarz, B. H., Meade-White, K. D., Porter, D., Schulz, J. E., van Doremalen, N., Leighton, I. A., Yinda, C. K., Pérez-Pérez, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2423-5 · Cited by 696 · see citing works

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Dinnon, K. H., Leist, S. R., Schäfer, A., Edwards, C. E., Martinez, D. R., Montgomery, S. A., West, A., Yount, B. L., Hou, Y. J., Adams, L. E., et al. (2020) · Nature · doi:10.1038/s41586-020-2708-8 · Cited by 675 · see citing works

Cultivation of a Novel Type of Common-cold Virus in Organ Cultures

Tyrrell, D. A. J., & Bynoe, M. L. (1965) · BMJ · doi:10.1136/bmj.1.5448.1467 · Cited by 623 · see citing works

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

Sun, S.-H., Chen, Q., Gu, H.-J., Yang, G., Wang, Y.-X., Huang, X.-Y., Liu, S.-S., Zhang, N.-N., Li, X.-F., Xiong, R., et al. (2020) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2020.05.020 · Cited by 617 · see citing works

The time course of the immune response to experimental coronavirus infection of man

Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598 · see citing works

A previously undescribed coronavirus associated with respiratory disease in humans

Fouchier, R. A. M., Hartwig, N. G., Bestebroer, T. M., Niemeyer, B., de Jong, J. C., Simon, J. H., & Osterhaus, A. D. M. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400762101 · Cited by 595 · see citing works

Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.

McIntosh, K., Dees, J. H., Becker, W. B., Kapikian, A. Z., & Chanock, R. M. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.4.933 · Cited by 589 · see citing works

Pathology and Pathogenesis of Severe Acute Respiratory Syndrome

Gu, J., & Korteweg, C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061088 · Cited by 583 · see citing works

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

Channappanavar, R., Fehr, A. R., Zheng, J. H., Wohlford-Lenane, C., Abrahante, J. E., Mack, M., Sompallae, R. R., McCray, P. B., Meyerholz, D. K., & Perlman, S. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126363 · Cited by 556 · see citing works

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2

Jiang, R.-D., Liu, M.-Q., Chen, Y., Shan, C., Zhou, Y.-W., Shen, X.-R., Li, Q., Zhang, L., Zhu, Y., Si, H.-R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.027 · Cited by 541 · see citing works

Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

Chan, J. F., Yuan, S., Zhang, J., Poon, V. K., Chan, C. C., Lee, A. C.-Y., Fan, Z., Li, C., Liang, R., Cao, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa644 · Cited by 529 · see citing works

Middle East Respiratory Syndrome

Arabi, Y. M., Balkhy, H. H., Hayden, F. G., Bouchama, A., Luke, T., Baillie, J. K., Al-Omari, A., Hajeer, A. H., Senga, M., Denison, M. R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmsr1408795 · Cited by 518 · see citing works

Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study

Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works

Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496 · see citing works

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Omrani, A. S., Saad, M. M., Baig, K. M., Bahloul, A., Abdul-Matin, M., Aidaroos, A. Y. A., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 493 · see citing works

T Cell Responses to Whole SARS Coronavirus in Humans

Li, C. K., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 488 · see citing works

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV

Lokugamage, K. G., Hage, A., de Vries, M., Valero-Jimenez, A. M., Schindewolf, C., Dittmann, M., Rajsbaum, R., & Menachery, V. D. (2020) · Journal of Virology · doi:10.1128/jvi.01410-20 · Cited by 485 · see citing works

Middle East respiratory syndrome

Memish, Z. A., Perlman, S. M., Kerkhove, M. D. V., & Zumla, A. I. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33221-0 · Cited by 484 · see citing works

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

Hassan, A. O., Case, J. B., Winkler, E. S., Thackray, L. B., Kafai, N. M., Bailey, A. L., McCune, B. T., Fox, J. M., Chen, R. E., Alsoussi, W. B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.011 · Cited by 477 · see citing works

Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells

Law, H., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, M. J. S., & Lau, Y. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 467 · see citing works

Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis

Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S. F., Wu, M. H. S., Chan, K., Yuen, K., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461 · see citing works

Rapid generation of a mouse model for Middle East respiratory syndrome

Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S., Fett, C., Zhao, J., Gale, M., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 453 · see citing works

Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways

Chu, H., Zhou, J., Wong, B. H.-Y., Li, C., Chan, J. F.-W., Cheng, Z.-S., Yang, D., Wang, D., Lee, A. C.-Y., Li, C., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv380 · Cited by 448 · see citing works

A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice

Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B. L., Vogel, L., Herman, B. D., Sheahan, T., Heise, M. T., Genrich, G. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030005 · Cited by 447 · see citing works

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques

Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445 · see citing works

Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection

Ng, O.-W., Chia, A., Tan, A. T., Jadi, R. S., Leong, H. N., Bertoletti, A., & Tan, Y.-J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.063 · Cited by 436 · see citing works

Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment

Sun, J., Zhuang, Z., Zheng, J. H., Li, K., Wong, R. L.-Y., Liu, D., Huang, J., He, J., Zhu, A., Zhao, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.010 · Cited by 434 · see citing works

Ten Strategies of Interferon Evasion by Viruses

García‐Sastre, A. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.012 · Cited by 429 · see citing works

Duration of Antibody Responses after Severe Acute Respiratory Syndrome

Wu, L.-P., Wang, N.-C., Chang, Y.-H., Tian, X.-Y., Na, D.-Y., Zhang, L.-Y., Zheng, L., Lan, T., Wang, L.-F., & Liang, G.-D. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1310.070576 · Cited by 426 · see citing works

Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis

Zhou, J., Chu, H., Li, C., Wong, B. H., Cheng, Z., Poon, V. K., Sun, T., Lau, C. C.-Y., Wong, K. K. Y., Chan, J. Y. W., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 425 · see citing works

Acute Respiratory Distress Syndrome in Critically Ill Patients With Severe Acute Respiratory Syndrome

Lew, T. W. K. (2003) · JAMA · doi:10.1001/jama.290.3.374 · Cited by 423 · see citing works

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

Bisht, H., Roberts, A., Vogel, L., Bukreyev, A. A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 415 · see citing works

COVID-19: the case for health-care worker screening to prevent hospital transmission

Black, J. R., Bailey, C., Przewrocka, J., Dijkstra, K. K., & Swanton, C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30917-x · Cited by 415 · see citing works

Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection

Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K., & Perlman, S. (2014) · Journal of Virology · doi:10.1128/jvi.01505-14 · Cited by 411 · see citing works

Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections

Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q., Zhao, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4594 · Cited by 401 · see citing works

Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+T Cells Are Important in Control of SARS-CoV Infection

Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2009) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 400 · see citing works

Coronavirus infection of the central nervous system: host–virus stand-off

Bergmann, C. C., Lane, T. E., & Stohlman, S. A. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1343 · Cited by 398 · see citing works

Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon

Cervantes‐Barragán, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V., & Ludewig, B. (2006) · Blood · doi:10.1182/blood-2006-05-023770 · Cited by 397 · see citing works

Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice

Subbarao, K., McAuliffe, J. M., Vogel, L., Fahle, G. A., Fischer, S. H., Tatti, K. M., Packard, M. M., Shieh, W., Zaki, S. R., & Murphy, B. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 397 · see citing works

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV

Liu, W. J., Zhao, M. J., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 395 · see citing works

Transmission of MERS-Coronavirus in Household Contacts

Drosten, C., Meyer, B., Müller, M. A., Corman, V. M., Almasri, M. M., Hossain, R., Madani, H. H., Sieberg, A., Bosch, B., Lattwein, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405858 · Cited by 393 · see citing works

Human immunopathogenesis of severe acute respiratory syndrome (SARS)

Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.014 · Cited by 391 · see citing works

Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome

Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00527-07 · Cited by 386 · see citing works

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014

Ng, D., Hosani, F. I. A., Keating, M. K., Gerber, S. I., Jones, T. L., Metcalfe, M. G., Tong, S., Tao, Y., Alami, N. N., Haynes, L. M., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.10.024 · Cited by 386 · see citing works

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

Buchholz, U. J., Bukreyev, A. A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385 · see citing works

Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages

Deng, X., Hackbart, M., Mettelman, R. C., O’Brien, A., Mielech, A. M., Yi, G., Kao, C. C., & Baker, S. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618310114 · Cited by 380 · see citing works

Review of Infectious Bronchitis Virus Around the World

Jackwood, M. W. (2012) · Avian Diseases · doi:10.1637/10227-043012-review.1 · Cited by 373 · see citing works

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

Corman, V. M., Albarrak, A. M., Omrani, A. S., Albarrak, M. M., Farah, M. E., Almasri, M. M., Muth, D., Sieberg, A., Meyer, B., Assiri, A. M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ951 · Cited by 370 · see citing works

Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling

Frieman, M. B., Ratia, K. M., Johnston, R. E., Mesecar, A. D., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02220-08 · Cited by 370 · see citing works

Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS

He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 365 · see citing works

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

Min, C.-K., Cheon, S., Ha, N., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J., Inn, K., Kim, J. H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364 · see citing works

Adaptive immune cells temper initial innate responses

Dong Kim, K., Zhao, J., Auh, S., Yang, X., Du, P., Tang, H., & Fu, Y.-X. (2007) · Nature Medicine · doi:10.1038/nm1633 · Cited by 348 · see citing works

T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice

Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340 · see citing works

Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome

Zhang, Y., Li, J., Zhan, Y., Wu, L., Xue-ying, Y., Zhang, W., Ye, L., Xu, S., Sun, R., Wang, Y., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4410-4415.2004 · Cited by 336 · see citing works

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus

Cavanagh, D. (2003) · Avian Pathology · doi:10.1080/03079450310001621198 · Cited by 333 · see citing works

MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study

Cho, S. Y., Kang, J., Ha, Y. E., Park, G. E., Lee, J. Y., Ko, J., Lee, J., Kim, J. M., Kang, C., Jo, I. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30623-7 · Cited by 318 · see citing works

Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome

Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S.-Q., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 317 · see citing works

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

Modjarrad, K., Roberts, C. C., Mills, K. T., Castellano, A. R., Paolino, K. M., Muthumani, K., Reuschel, E. L., Robb, M. L., Racine, T., Oh, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30266-x · Cited by 308 · see citing works

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

de Wit, E., Rasmussen, A. L., Falzarano, D., Bushmaker, T., Feldmann, F., Brining, D. L., Fischer, E. R., Martellaro, C., Okumura, A., Chang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310744110 · Cited by 305 · see citing works

Effects of a "new" human respiratory virus in volunteers.

Bradburne, A. F., Bynoe, M. L., & Tyrrell, D. A. J. (1967) · BMJ · doi:10.1136/bmj.3.5568.767 · Cited by 304 · see citing works

Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus

Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 298 · see citing works

Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome

Reghunathan, R., Jayapal, M., Hsu, L. Y., Chng, H. H., Tai, D. Y. H., Leung, B. P. L., & Melendez, A. J. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-2 · Cited by 295 · see citing works

Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells

Yoshikawa, T., Hill, T. E., Li, K., Peters, C. J., & Tseng, C.-T. K. (2008) · Journal of Virology · doi:10.1128/jvi.01792-08 · Cited by 291 · see citing works

The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination

Hu, Y., Li, W., Gao, T., Cui, Y., Jin, Y., Li, P., Ma, Q., Liu, X. E., & Cao, C. (2017) · Journal of Virology · doi:10.1128/jvi.02143-16 · Cited by 291 · see citing works

Impaired Antibody-Mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus

Habibi, M. S., Jóźwik, A., Makris, S., Dunning, J. W., Paras, A., DeVincenzo, J. P., de Haan, C. A. M., Wrammert, J., Openshaw, P., & Chiu, C. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2256oc · Cited by 289 · see citing works

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

Yang, P., Gu, H., Zhao, Z., Wang, W., Cao, B., Lai, C., Yang, X., Zhang, L., Duan, Y., Zhang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07027 · Cited by 283 · see citing works

Histopathology of Middle East respiratory syndrome coronovirus ( MERS ‐CoV) infection – clinicopathological and ultrastructural study

Alsaad, K. O., Hajeer, A. H., Balwi, M. A. A., Almoaiqel, M., Aloudah, N., Ajlan, A. A., AlJohani, S. M., Alsolamy, S. J., Gmati, G. E. M., Balkhy, H. H., et al. (2017) · Histopathology · doi:10.1111/his.13379 · Cited by 280 · see citing works

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel

Adams, E. R., Ainsworth, M. A., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E. J., Beer, S., Bell, J. I., Berry, T., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15927.1 · Cited by 278 · see citing works

Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

Vennema, H., de Groot, R. J., Harbour, D. A., Dalderup, M. J. M., Gruffydd-Jones, T., Horzinek, M. C., & Spaan, W. J. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1407-1409.1990 · Cited by 276 · see citing works

Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

Deming, D., Sheahan, T. P., Heise, M. T., Yount, B. L., Davis, N., Sims, A. M., Suthar, M. S., Harkema, J. R., Whitmore, A. C., Pickles, R. J., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 273 · see citing works

Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology

Zhao, L., Jha, B. K., Wu, A. Y., Elliott, R., Ziebuhr, J., Gorbalenya, A. E., Silverman, R. H., & Weiss, S. R. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.011 · Cited by 272 · see citing works

Bovine Respiratory Coronavirus

Saif, L. J. (2010) · Veterinary Clinics of North America: Food Animal Practice · doi:10.1016/j.cvfa.2010.04.005 · Cited by 270 · see citing works

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

Martin, J. E., Louder, M. K., Holman, L. A., Gordon, I. J., Enama, M. E., Larkin, B. D., Andrews, C. A., Vogel, L., Koup, R. A., Roederer, M., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.026 · Cited by 267 · see citing works

Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice

Zhao, J., Zhao, J., Legge, K., & Perlman, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59777 · Cited by 265 · see citing works

Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses

Zhao, J., Alshukairi, A. N., Baharoon, S. A., Ahmed, W., Bokhari, A. A., Nehdi, A., Layqah, L. A., Alghamdi, M., Algethamy, M., Dada, A. M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5393 · Cited by 259 · see citing works

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

He, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., & Dwyer, D. E. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.014 · Cited by 257 · see citing works

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus

Hsueh, P., Huang, L., Chen, P., Kao, C., & Yang, P. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01009.x · Cited by 255 · see citing works

Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study

Arabi, Y. M., Shalhoub, S., Mandourah, Y., Al-Hameed, F. M., Al‐Omari, A., Qasim, E. A., Jose, J., Alraddadi, B. M., Almotairi, A., Khatib, K. A., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz544 · Cited by 248 · see citing works

Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus Receptor

Tseng, C.-T. K., Huang, C., Newman, P. C., Wang, N., Narayanan, K., Watts, D. M., Makino, S., Packard, M. M., Zaki, S. R., Chan, T., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01702-06 · Cited by 244 · see citing works

Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever

Weiss, R. C., & Scott, F. W. (1981) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/0147-9571(81)90003-5 · Cited by 242 · see citing works

The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection

Fehr, A. R., Channappanavar, R., Jankevicius, G., Fett, C., Zhao, J., Athmer, J., Meyerholz, D. K., Ahel, I., & Perlman, S. M. (2016) · mBio · doi:10.1128/mbio.01721-16 · Cited by 234 · see citing works

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

Tang, X.-C., Agnihothram, S. S., Jiao, Y., Stanhope, J., Graham, R. L., Peterson, E. C., Avnir, Y., Tallarico, A. S. C., Sheehan, J., Zhu, Q., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402074111 · Cited by 232 · see citing works

Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication

Kindler, E., Gil‐Cruz, C., Spanier, J., Li, Y., Wilhelm, J., Rabouw, H. H., Züst, R., Hwang, M., V’kovski, P., Stalder, H., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006195 · Cited by 230 · see citing works

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

Folegatti, P. M., Bittaye, M., Flaxman, A. L., Lopez, F. R., Bellamy, D. G., Kupke, A., Mair, C., Makinson, R., Sheridan, J., Rohde, C., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30160-2 · Cited by 230 · see citing works

COVID-19 and Postinfection Immunity

Kirkcaldy, R. D., King, B. A., & Brooks, J. T. (2020) · JAMA · doi:10.1001/jama.2020.7869 · Cited by 230 · see citing works

Acquisition of Macrophage Tropism during the Pathogenesis of Feline Infectious Peritonitis Is Determined by Mutations in the Feline Coronavirus Spike Protein

Rottier, P. J. M., Nakamura, K., Schellen, P., Volders, H. H., & Haijema, B. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14122-14130.2005 · Cited by 229 · see citing works

Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia

Roth-Cross, J. K., Bender, S. J., & Weiss, S. R. (2008) · Journal of Virology · doi:10.1128/jvi.01199-08 · Cited by 228 · see citing works

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

Corti, D., Zhao, J., Pedotti, M., Simonelli, L., Agnihothram, S., Fett, C., Fernandez-Rodriguez, B., Foglierini, M., Agatic, G., Vanzetta, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510199112 · Cited by 216 · see citing works

Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2′-O-Methyltransferase Activity

Menachery, V. D., Yount, B. L., Josset, L., Gralinski, L. E., Scobey, T., Agnihothram, S., Katze, M. G., & Baric, R. S. (2014) · Journal of Virology · doi:10.1128/jvi.03571-13 · Cited by 213 · see citing works

Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry

Collisson, E. W. (2000) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(99)00072-5 · Cited by 210 · see citing works

A novel variant of avian infectious bronchitis virus resulting from recombination among three different strains

Jia, W., Karaca, K., Parrish, C. R., & Naqi, S. A. (1995) · Archives of Virology · doi:10.1007/bf01309861 · Cited by 210 · see citing works

Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset

Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A. L., Okumura, A., Peng, X., Thomas, M. J., van Doremalen, N., Haddock, E., Nagy, L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004250 · Cited by 209 · see citing works

A mouse model for MERS coronavirus-induced acute respiratory distress syndrome

Cockrell, A. S., Yount, B. L., Scobey, T., Jensen, K., Douglas, M. G., Beall, A. E., Tang, X.-C., Marasco, W. A., Heise, M. T., & Baric, R. S. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.226 · Cited by 207 · see citing works

Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly Humans

Roberts, A., Paddock, C. D., Vogel, L., Butler, E. L., Zaki, S. R., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5833-5838.2005 · Cited by 196 · see citing works

Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection

Kim, E. S., Choe, P. G., Park, W. B., Oh, H. S., Kim, E. J., Nam, E. Y., Na, S. H., Kim, M., Song, K., Bang, J. H., et al. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.11.1717 · Cited by 193 · see citing works

MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape

Menachery, V. D., Schäfer, A., Burnum-Johnson, K., Mitchell, H. D., Eisfeld, A. J., Walters, K., Nicora, C., Purvine, S. O., Casey, C., Monroe, M. E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706928115 · Cited by 193 · see citing works

CD4 and CD8 T Cells Have Redundant But Not Identical Roles in Virus-Induced Demyelination

Wu, G. F., Dandekar, A. A., Pewe, L., & Perlman, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2278 · Cited by 192 · see citing works

MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity

Chu, D. K. W., Hui, K. P. Y., Perera, R. A. P. M., Miguel, E., Niemeyer, D., Zhao, J., Channappanavar, R., Dudas, G., Oladipo, J. O., Traoré, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718769115 · Cited by 191 · see citing works

SARS-coronavirus replication in human peripheral monocytes/macrophages

Yilla, M., Harcourt, B. H., Hickman, C. J., McGrew, M., Tamin, A., Goldsmith, C. S., Bellini, W. J., & Anderson, L. J. (2004) · Virus Research · doi:10.1016/j.virusres.2004.09.004 · Cited by 190 · see citing works

Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells

Williamson, J. S., & Stohlman, S. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4589-4592.1990 · Cited by 185 · see citing works

Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals

Zhang, L., Zhang, F., Yu, W., Tian, H., Yu, J., Yi, C. E., Ba, L., Li, W., Farzan, M., Chen, Z., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20499 · Cited by 184 · see citing works

Animal models for SARS and MERS coronaviruses

Gretebeck, L., & Subbarao, K. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.06.009 · Cited by 181 · see citing works

Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice

Li, K., Wohlford-Lenane, C., Channappanavar, R., Park, J.-E., Earnest, J. T., Bair, T., Bates, A. M., Brogden, K. A., Flaherty, H. A., Gallagher, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619109114 · Cited by 181 · see citing works

Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response

Chu, H., Zhou, J., Wong, B. H., Li, C., Cheng, Z., Lin, X., Poon, V. K., Sun, T., Lau, C. C.-Y., Chan, J. F., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 178 · see citing works

Relationship between sequence variation in the S1 spike protein of infectious bronchitis virus and the extent of cross‐protection in vivo

Cavanagh, D. R., Elus, M. M., & Cook, J. K. A. (1997) · Avian Pathology · doi:10.1080/03079459708419194 · Cited by 176 · see citing works

Genetic evolution and tropism of transmissible gastroenteritis coronaviruses

Sánchez, C. M., Gebauer, F., Suñé, C., Méndez, A., Dopazo, J., & Enjuanes, L. (1992) · Virology · doi:10.1016/0042-6822(92)91195-z · Cited by 173 · see citing works

Mandell, Douglas, and Bennett's Principles and practice of Infectious Diseases

Wright, S. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)90043-5 · Cited by 169 · see citing works

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape

Wang, L., Shi, W., Chappell, J. D., Joyce, M. G., Zhang, Y., Kanekiyo, M., Becker, M. M., van Doremalen, N., Fischer, R., Wang, N., et al. (2018) · Journal of Virology · doi:10.1128/jvi.02002-17 · Cited by 169 · see citing works

Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine

Lin, J., Zhang, J., Su, N., Xu, J., Wang, N., Chen, J.-T., Chen, X., Liu, Y.-X., Gao, H., Jia, Y.-P., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200702 · Cited by 168 · see citing works

Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated

Wang, F.-I., Stohlman, S. A., & Fleming, J. O. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90050-w · Cited by 165 · see citing works

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

Gorse, G. J., Patel, G. B., Vitale, J. N., & O’Connor, T. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00278-10 · Cited by 165 · see citing works

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Koch, T., Dahlke, C., Fathi, A., Kupke, A., Krähling, V., Okba, N. M. A., Halwe, S., Rohde, C., Eickmann, M., Volz, A., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30248-6 · Cited by 163 · see citing works

Highly Activated Cytotoxic CD8 T Cells Express Protective IL-10 at the Peak of Coronavirus-Induced Encephalitis

Trandem, K., Zhao, J., Fleming, E., & Perlman, S. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003292 · Cited by 158 · see citing works

Ferret models of viral pathogenesis

Enkirch, T., & von Messling, V. (2015) · Virology · doi:10.1016/j.virol.2015.03.017 · Cited by 156 · see citing works

Isolation and Characterization of Current Human Coronavirus Strains in Primary Human Epithelial Cell Cultures Reveal Differences in Target Cell Tropism

Dijkman, R., Jebbink, M. F., Koekkoek, S. M., Deijs, M., Jónsdóttir, H. R., Molenkamp, R., Ieven, M. M., Goossens, H., Thiel, V., & van der Hoek, L. (2013) · Journal of Virology · doi:10.1128/jvi.03368-12 · Cited by 155 · see citing works

Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice

Zhao, J., Zhao, J., van Rooijen, N., & Perlman, S. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000636 · Cited by 151 · see citing works

Strategies for Design and Application of Enteric Viral Vaccines

Chattha, K. S., Roth, J. A., & Saif, L. J. (2014) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022114-111038 · Cited by 151 · see citing works

Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection

Fan, Y., Huang, Z., Li, L., Wu, M., Yu, T., Koup, R. A., Bailer, R. T., & Wu, C. Y. (2009) · Archives of Virology · doi:10.1007/s00705-009-0409-6 · Cited by 150 · see citing works

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea

Park, W. B., Perera, R. A. P. M., Choe, P. G., Lau, E. H. Y., Choi, S. J., Chun, J. Y., Oh, H. S., Song, K., Bang, J. H., Kim, E. S., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2112.151421 · Cited by 150 · see citing works

Cross-protection studies between respiratory and calf diarrhea and winter dysentery coronavirus strains in calves and RT-PCR and nested PCR for their detection

Cho, K.-O., Hasöksüz, M., Nielsen, P. R., Chang, K., Lathrop, S. L., & Saif, L. J. (2001) · Archives of Virology · doi:10.1007/s007050170011 · Cited by 148 · see citing works

Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection

Shin, H., Kim, Y., Kim, G., Lee, J. Y., Jeong, I., Joh, J.-S., Kim, H., Chang, E., Sim, S. Y., Park, J.-S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy595 · Cited by 148 · see citing works

Antibody responses to individual proteins of SARS coronavirus and their neutralization activities

Qiu, M., Shi, Y., Guo, Z., Chen, Z., He, R., Chen, R., Zhou, D., Dai, E., Wang, X., Si, B., et al. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.02.006 · Cited by 147 · see citing works

The Tecumseh Study of Respiratory Illness. VI. Frequency of and Relationship between Outbreaks of Coronavims Infection

Monto, A. S., & Lim, S. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/129.3.271 · Cited by 146 · see citing works

Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human Disease

Frieman, M. B., Yount, B. L., Agnihothram, S., Page, C., Donaldson, E., Roberts, A., Vogel, L., Woodruff, B., Scorpio, D. G., Subbarao, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05957-11 · Cited by 141 · see citing works

Intranasal Treatment with Poly(I·C) Protects Aged Mice from Lethal Respiratory Virus Infections

Zhao, J., Wohlford-Lenane, C., Zhao, J., Fleming, E., Lane, T. E., McCray, P. B., & Perlman, S. M. (2012) · Journal of Virology · doi:10.1128/jvi.01410-12 · Cited by 140 · see citing works

Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro

Yen, Y., Liao, F., Hsiao, C.-H., Kao, C., Chen, Y., & Wu‐Hsieh, B. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2684-2693.2006 · Cited by 140 · see citing works

The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement

Quinlan, B. D., Mou, H., Zhang, L., Guo, Y., He, W., Ojha, A., Parcells, M. S., Luo, G., Li, W., Zhong, G., et al. (2020) · doi:10.1101/2020.04.10.036418 · Cited by 140 · see citing works

Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome–CoV infection

Vijay, R., Hua, X., Meyerholz, D. K., Miki, Y., Yamamoto, K., Gelb, M. H., Murakami, M., & Perlman, S. M. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150632 · Cited by 139 · see citing works

Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine

Iwata‐Yoshikawa, N., Uda, A., Suzuki, T., Tsunetsugu‐Yokota, Y., Sato, Y., Morikawa, S., Tashiro, M., Sata, T., Hasegawa, H., & Nagata, N. (2014) · Journal of Virology · doi:10.1128/jvi.00983-14 · Cited by 130 · see citing works

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

and the Saudi Critical Care Trials group, Arabi, Y. M., Asiri, A. Y., Assiri, A. M., Jokhdar, H., Alothman, A. F., Balkhy, H. H., AlJohani, S. M., Harbi, S. A. A., Kojan, S. M., et al. (2020) · Trials · doi:10.1186/s13063-019-3846-x · Cited by 128 · see citing works

Thinking Outside the Triangle: Replication Fidelity of the Largest RNA Viruses

Smith, E. C., Sexton, N. R., & Denison, M. R. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085507 · Cited by 125 · see citing works

Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection

Cervantes‐Barragán, L., Kalinke, U., Züst, R., König, M. F., Reizis, B., López-Macías, C. I. R., Thiel, V., & Ludewig, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1099 · Cited by 124 · see citing works

High Secretion of Interferons by Human Plasmacytoid Dendritic Cells upon Recognition of Middle East Respiratory Syndrome Coronavirus

Scheuplein, V., Seifried, J., Malczyk, A. H., Miller, L., Höcker, L., Vergara‐Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03607-14 · Cited by 123 · see citing works

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome

Lee, N. L. S., Chan, P. K. S., Ip, M., Wong, E., Ho, J., Ho, C., Cockram, C. S., & Hui, D. S. C. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.07.005 · Cited by 119 · see citing works

Coronavirus infections in working adults. Eight-year study with 229 E and OC 43.

Hendley, J. O., Fishburne, H. B., & Gwaltney, J. M. (1972) · PubMed · doi:10.1164/arrd.1972.105.5.805 · Cited by 118 · see citing works

Middle East Respiratory Syndrome

Shalhoub, S., Memish, Z. A., & Arabi, Y. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-54841-0.00004-4 · Cited by 113 · see citing works

Antibody Prevents Virus Reactivation Within the Central Nervous System

Lin, M. T., Hinton, D. R., Marten, N. W., Bergmann, C. C., & Stohlman, S. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7358 · Cited by 106 · see citing works

Type I Interferons Are Essential in Controlling Neurotropic Coronavirus Infection Irrespective of Functional CD8 T Cells

Ireland, D. D. C., Stohlman, S. A., Hinton, D. R., Atkinson, R., & Bergmann, C. C. (2007) · Journal of Virology · doi:10.1128/jvi.01794-07 · Cited by 104 · see citing works

Perforin and Gamma Interferon-Mediated Control of Coronavirus Central Nervous System Infection by CD8 T Cells in the Absence of CD4 T Cells

Bergmann, C. C., Parra, B., Hinton, D. R., Ramakrishna, C., Dowdell, K. C., & Stohlman, S. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1739-1750.2004 · Cited by 103 · see citing works

CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity

Castro, R. F., & Perlman, S. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8127-8131.1995 · Cited by 103 · see citing works

Induction of Alternatively Activated Macrophages Enhances Pathogenesis during Severe Acute Respiratory Syndrome Coronavirus Infection

Page, C., Goicochea, L., Matthews, K. L., Zhang, Y., Klover, P. J., Holtzman, M. J., Hennighausen, L. G., & Frieman, M. B. (2012) · Journal of Virology · doi:10.1128/jvi.01689-12 · Cited by 102 · see citing works

Isolation of Porcine Immunoglobulins and Determination of the Immunoglobulin Classes of Transmissible Gastroenteritis Viral Antibodies

Saif, L. J., Bohl, E. H., & Gupta, R. (1972) · Infection and Immunity · doi:10.1128/iai.6.4.600-609.1972 · Cited by 96 · see citing works

IFN-γ– and IL-10–expressing virus epitope-specific Foxp3+ T reg cells in the central nervous system during encephalomyelitis

Zhao, J., Zhao, J., Fett, C., Trandem, K., Fleming, E., & Perlman, S. M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110236 · Cited by 93 · see citing works

Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare WorkersPreprint

Guo, X., Guo, Z., Duan, C., Chen, Z., Wang, G., Lu, Y., Li, M., & Lu, J. (2020) · medRxiv · doi:10.1101/2020.02.12.20021386 · Cited by 92 · see citing works

Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers

Higgins, P. G., Phillpotts, R. J., Scott, G. M., Wallace, J., Bernhardt, L. L., & Tyrrell, D. A. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.5.713 · Cited by 90 · see citing works

B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike Glycoprotein

Zhong, X., Yang, H., Guo, Z., Sin, W.-Y. F., Chen, W., Xu, J., Fu, L. L., Wu, J., Mak, C.-K. G., Cheng, C.-S. S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3401-3408.2005 · Cited by 89 · see citing works

Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells

Tynell, J., Westenius, V., Rönkkö, E., Munster, V. J., Melén, K., Österlund, P., & Julkunen, I. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000351 · Cited by 88 · see citing works

Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants

Tai, W., Wang, Y., Fett, C., Zhao, G., Li, F., Perlman, S. M., Jiang, S., Zhou, Y., & Du, L. (2016) · Journal of Virology · doi:10.1128/jvi.01651-16 · Cited by 85 · see citing works

Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope

Oh, H. J., Chia, A., Chang, C. X. L., Leong, H. N., Ling, K. L., Grotenbreg, G. M., Gehring, A. J., Tan, Y., & Bertoletti, A. (2011) · Journal of Virology · doi:10.1128/jvi.05039-11 · Cited by 84 · see citing works

Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS)

McIntosh, K., & Perlman, S. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00157-0 · Cited by 81 · see citing works

Inability To Evoke a Long-Lasting Protective Immune Response to Respiratory Syncytial Virus Infection in Mice Correlates with Ineffective Nasal Antibody Responses

Singleton, R., Etchart, N., Hou, S., & Hyland, L. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11303-11311.2003 · Cited by 77 · see citing works

Cutting Edge: CD8 T Cell-Mediated Demyelination Is IFN-γ Dependent in Mice Infected with a Neurotropic Coronavirus

Pewe, L. L., & Perlman, S. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1547 · Cited by 77 · see citing works

A longitudinal study of bovine coronavirus enteric and respiratory infections in dairy calves in two herds in Ohio

Heckert, R. A., Saif, L. J., Hoblet, K. H., & Agnes, A. G. (1990) · Veterinary Microbiology · doi:10.1016/0378-1135(90)90106-6 · Cited by 75 · see citing works

Mouse hepatitis virus strain — Related patterns of tissue tropism in suckling mice

Barthold, S. W., & Smith, A. L. (1984) · Archives of Virology · doi:10.1007/bf01309300 · Cited by 73 · see citing works

Role of regulatory T cells in coronavirus-induced acute encephalitis

Anghelina, D., Zhao, J., Trandem, K., & Perlman, S. M. (2009) · Virology · doi:10.1016/j.virol.2008.12.014 · Cited by 73 · see citing works

Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine

Gerber, J. D., Ingersoll, J. D., Gast, A., Christianson, K. K., Selzer, N. L., Landon, R. M., Pfeiffer, N. E., Sharpee, R. L., & Beckenhauer, W. H. (1990) · Vaccine · doi:10.1016/0264-410x(90)90004-6 · Cited by 68 · see citing works

CD8 + T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome

Coleman, C. M., Sisk, J. M., Halász, G., Zhong, J., Beck, S. E., Matthews, K. L., Venkataraman, T., Rajagopalan, S., Kyratsous, C. A., & Frieman, M. B. (2016) · Journal of Virology · doi:10.1128/jvi.01825-16 · Cited by 65 · see citing works

Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus

Kim, M. H., Kim, H. J., & Chang, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220196 · Cited by 63 · see citing works

Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions

Fehr, D., Holznagel, E., Bolla, S., Hauser, B., Herrewegh, A. A. P. M., Horzinek, M. C., & Lutz, H. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00006-6 · Cited by 62 · see citing works

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · see citing works

Adaptive immunity to SARS-CoV-2 and COVID-19

Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works

Viral targets for vaccines against COVID-19

Dai, L., & Gao, G. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00480-0 · Cited by 949 · see citing works

Immunological considerations for COVID-19 vaccine strategies

Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015 · see citing works

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

Grant, R. A., Morales‐Nebreda, L., Markov, N. S., Swaminathan, S., Querrey, M., Rios-Guzman, E., Abbott, D. A., Donnelly, H. K., Donayre, A., Goldberg, I. A., et al. (2021) · Nature · doi:10.1038/s41586-020-03148-w · Cited by 703 · see citing works

The dawn of mRNA vaccines: the COVID-19 case

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504 · see citing works

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Supasa, P., Zhou, D., Dejnirattisai, W., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H. M. E., Nutalai, R., Tuekprakhon, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.033 · Cited by 460 · see citing works

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Klein, S. L., Pekosz, A. S., Park, H.-S., Ursin, R. L., Shapiro, J. R., Benner, S. E., Littlefield, K. E., Kumar, S., Naik, H. M., Betenbaugh, M. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142004 · Cited by 424 · see citing works

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19

Ward, B. J., Gobeil, P., Séguin, A., Atkins, J., Boulay, I., Charbonneau, P.-Y., Couture, M., D’Aoust, M., Dhaliwall, J. K., Finkle, C. D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01370-1 · Cited by 361 · see citing works

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.050 · Cited by 340 · see citing works

Recent endemic coronavirus infection is associated with less severe COVID-19

Sagar, M., Reifler, K., Rossi, M., Miller, N. S., Sinha, P., White, L. F., & Mizgerd, J. P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143380 · Cited by 324 · see citing works

Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study

Foy, B. H., Wahl, B., Mehta, K., Shet, A., Menon, G. I., & Britto, C. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.075 · Cited by 241 · see citing works

Vaccines for COVID-19

Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.-M., Pierce, B. F., Stirling, D. C., Wang, Z., & Pollock, K. M. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13517 · Cited by 222 · see citing works

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses

Bonifacius, A., Tischer-Zimmermann, S., Dragon, A., Gussarow, D., Vogel, A. J., Krettek, U., Gödecke, N., Yilmaz, M., Kraft, A. R. M., Hoeper, M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.008 · Cited by 186 · see citing works

Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection

Zheng, M., Williams, E. P., Malireddi, R. K. S., Karki, R., Banoth, B., Burton, A. R., Webby, R. J., Channappanavar, R., Jonsson, C. B., & Kanneganti, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015036 · Cited by 205 · see citing works

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Siegel, C. A., MELMED, G. Y., McGovern, D. P. B., Rai, V., Krammer, F., Rubin, D. T., Abreu, M. T., & Dubinsky, M. C. (2021) · Gut · doi:10.1136/gutjnl-2020-324000 · Cited by 179 · see citing works

Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome

Sukocheva, O. A., Maksoud, R., Beeraka, N. M., Madhunapantula, S. V., Sinelnikov, M. Y., Nikolenko, V. N., Евгеньевна, Н. М., Klochkov, S. G., Kamal, M. A., Staines, D., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.013 · Cited by 172 · see citing works

Antibody and B cell responses to SARS-CoV-2 infection and vaccination

Röltgen, K., & Boyd, S. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.009 · Cited by 136 · see citing works

Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity

López-Muñoz, A. D., Košík, I., Hollý, J., & Yewdell, J. W. (2022) · Science Advances · doi:10.1126/sciadv.abp9770 · Cited by 132 · see citing works

Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionPreprint

Dan, J., Mateus, J., Kato, Y., Hastie, K., Yu, E., Faliti, C. E., Grifoni, A., Ramirez, S., Haupt, S., Frazier, A., et al. (2020) · bioRxiv · doi:10.1101/2020.11.15.383323 · Cited by 147 · see citing works

Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19

You, M., Chen, L., Zhang, D., Zhao, P., Chen, Z., Qin, E., Gao, Y., Davis, M. M., & Yang, P. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00690-1 · Cited by 116 · see citing works

A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges

Rahman, M. M., Masum, M. H. U., Wajed, S., & Talukder, A. (2022) · VirusDisease · doi:10.1007/s13337-022-00755-1 · Cited by 112 · see citing works

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2

Granados-Riveron, J. T., & Aquino‐Jarquín, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111953 · Cited by 115 · see citing works

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times

Montero, C. G., Fraile‐Μartinez, O., Bravo, C., Torres‐Carranza, D., Sánchez‐Trujillo, L., Gomez-Lahoz, A. M., Guijarro, L. G., García‐Honduvilla, N., Asúnsolo, Á., Buján, J., et al. (2021) · Vaccines · doi:10.3390/vaccines9050433 · Cited by 109 · see citing works

Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection

Yang, Y., Yang, M., Peng, Y., Liang, Y., Wei, J., Xing, L., Guo, L., Li, X., Li, J., Wang, J., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01051-2 · Cited by 109 · see citing works

Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.

Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2020) · eScholarship (California Digital Library) · Cited by 121 · see citing works

Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses

Jordan, S. C. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13582 · Cited by 106 · see citing works

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation

King, C., & Sprent, J. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.02.003 · Cited by 101 · see citing works

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections

Babiker, A., Marvil, C., Waggoner, J., Collins, M., & Piantadosi, A. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02769-20 · Cited by 92 · see citing works

Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity

Channappanavar, R., & Perlman, S. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci144115 · Cited by 92 · see citing works

Immunobiology and immunotherapy of COVID‐19: A clinically updated overview

Esmaeilzadeh, A., & Elahi, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30076 · Cited by 92 · see citing works

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Routhu, N. K., Cheedarla, N., Bollimpelli, V. S., Gangadhara, S., Edara, V. V., Lai, L., Sahoo, A., Shiferaw, A., Styles, T. M., Floyd, K. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23942-y · Cited by 92 · see citing works

COVID-19 Pandemic: Is Africa Different?

Bamgboye, E. L., Omiye, J. A., Afolaranmi, O. J., Davids, M. R., Tannor, E. K., Wadee, S., Niang, A., Were, A. J. O., & Naicker, S. (2020) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.10.001 · Cited by 89 · see citing works

Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs

Malone, B., Simovski, B., Moliné, C., Cheng, J., Gheorghe, M., Fontenelle, H., Vardaxis, I., Tennøe, S., Malmberg, J.-A., Stratford, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78758-5 · Cited by 85 · see citing works

Discrete SARS-CoV-2 antibody titers track with functional humoral stability

Bartsch, Y. C., Fischinger, S., Siddiqui, S. M., Chen, Z., Yu, J., Gebre, M., Atyeo, C., Gorman, M. J., Zhu, A. L., Kang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21336-8 · Cited by 82 · see citing works

T cells in COVID-19 — united in diversity

Swadling, L., & Maini, M. K. (2020) · Nature Immunology · doi:10.1038/s41590-020-0798-y · Cited by 77 · see citing works

The role of B cells in COVID-19 infection and vaccination

Chen, S., Guan, F., Candotti, F., Benlagha, K., Câmara, N. O. S., Herrada, A. A., James, L. K., Lei, J., Miller, H., Kubo, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988536 · Cited by 74 · see citing works

Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?

Hamady, A., Lee, J., & Loboda, Z. (2021) · Infection · doi:10.1007/s15010-021-01664-z · Cited by 65 · see citing works

Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2

Stephensen, C. B., & Lietz, G. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521000246 · Cited by 66 · see citing works

Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2

Zhao, H., To, K. K., Lam, H., Zhou, X., Chan, J. F., Peng, Z., Lee, A. C.-Y., Cai, J., Chan, W.-M., Ip, J. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21825-w · Cited by 65 · see citing works

Extracellular RNA as a Versatile DAMP and Alarm Signal That Influences Leukocyte Recruitment in Inflammation and Infection

Preissner, K. T., Fischer, S., & Deindl, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.619221 · Cited by 66 · see citing works

Defending against SARS-CoV-2: The T cell perspective

Almendro-Vázquez, P., Laguna‐Goya, R., & Paz‐Artal, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107803 · Cited by 64 · see citing works

N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence

Wong, K. K., Lee, S. W. H., & Kua, K. P. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s306849 · Cited by 59 · see citing works

Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

Almendro-Vázquez, P., Laguna‐Goya, R., Ruiz‐Ruigómez, M., Utrero‐Rico, A., Lalueza, A., de la Calle, G. M., Delgado, P., Ordoño, L. P., Muro, E., Vila, J. J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010211 · Cited by 59 · see citing works

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

Bachmann, M. F., Mohsen, M. O., Zha, L., Vogel, M., & Speiser, D. E. (2021) · npj Vaccines · doi:10.1038/s41541-020-00264-6 · Cited by 57 · see citing works

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2

Koch, C. M., Prigge, A. D., Anekalla, K. R., Shukla, A., Umehara, H. C. D., Setar, L., Chavez, J., Abdala‐Valencia, H., Politanska, Y., Markov, N. S., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0292oc · Cited by 56 · see citing works

Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy

Tamari, R., Politikos, I., Knorr, D. A., Vardhana, S. A., Young, J. C., Marcello, L. T., Doddi, S., Devlin, S. M., Ramanathan, L. V., Pessin, M. S., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0142 · Cited by 58 · see citing works

Covid-19 vaccines: delivering protective immunity

Sewell, H. F., Agius, R. M., Kendrick, D., & Stewart, M. (2020) · BMJ · doi:10.1136/bmj.m4838 · Cited by 57 · see citing works

Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine

Agrati, C., Castilletti, C., Goletti, D., Meschi, S., Sacchi, A., Matusali, G., Bordoni, V., Petrone, L., Lapa, D., Notari, S., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9061315 · Cited by 58 · see citing works

Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysisPreprint

Wu, F., Yan, R., Liu, M., Liu, Z., Wang, Y., Luan, D., Wu, K., Song, Z., Sun, T., Ma, Y., et al. (2020) · medRxiv · doi:10.1101/2020.10.08.20209114 · Cited by 53 · see citing works

SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern

Lu, M., Chamblee, M., Zhang, Y., Ye, C., Dravid, P., Park, J., Mahesh, K., Trivedi, S., Murthy, S. S., Sharma, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110105119 · Cited by 54 · see citing works

Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components

Priyanka, Choudhary, O. P., & Singh, I. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101911 · Cited by 54 · see citing works

A lymph node–targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2

Steinbuck, M. P., Seenappa, L. M., Jakubowski, A., McNeil, L. K., Haqq, C. M., & DeMuth, P. C. (2021) · Science Advances · doi:10.1126/sciadv.abe5819 · Cited by 49 · see citing works

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

Andrade, V. M., Christensen-Quick, A., Agnes, J. T., Tur, J., Reed, C., Kalia, R., Marrero, I., Elwood, D., Schultheis, K., Purwar, M., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00384-7 · Cited by 51 · see citing works

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines

Kremer, E. J. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.002 · Cited by 53 · see citing works

Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months

Breathnach, A. S., Riley, P. A., Cotter, M., Houston, A., Habibi, M. S., & Planche, T. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.01.005 · Cited by 51 · see citing works

Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses

Cueno, M. E., & Imai, K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.594439 · Cited by 51 · see citing works

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles

Zha, L., Chang, X., Zhao, H., Mohsen, M. O., Hong, L., Zhou, Y., Chen, H., Liu, X., Zhang, J., Li, D., et al. (2021) · Vaccines · doi:10.3390/vaccines9040395 · Cited by 49 · see citing works

Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells

Hafezi, B., Chan, L., Knapp, J. P., Karimi, N., Alizadeh, K., Mehrani, Y., Bridle, B. W., & Karimi, K. (2021) · Cells · doi:10.3390/cells10071761 · Cited by 52 · see citing works

Differential immune responses in pregnant patients recovered from COVID-19

Chen, G., Zhang, Y., Zhang, Y., Ai, J., Yang, B., Cui, M., Liao, Q., Chen, H., Bai, H., Shang, D., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00703-3 · Cited by 48 · see citing works

Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs

Thura, M., Sng, J., Ang, K. H., Li, J., Gupta, A. K., Hong, J. M., Hong, C. W., & Zeng, Q. (2021) · Bioscience Reports · doi:10.1042/bsr20211491 · Cited by 49 · see citing works

Commentary on the use of the reproduction number R during the COVID-19 pandemic

Vegvari, C., Abbott, S., Ball, F., Brooks‐Pollock, E., Challen, R., Collyer, B. S., Dangerfield, C. E., Gog, J. R., Gostic, K. M., Heffernan, J. M., et al. (2021) · Statistical Methods in Medical Research · doi:10.1177/09622802211037079 · Cited by 51 · see citing works

Non-human primate models of human respiratory infections

Lemaître, J., Naninck, T., Delache, B., Creppy, J., Huber, P., Holzapfel, M., Bouillier, C., Contreras, V., Martinon, F., Kahlaoui, N., et al. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.04.010 · Cited by 45 · see citing works

Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.

Montesinos, I., Dahma, H., Wolff, F., Dauby, N., Delaunoy, S., Wuyts, M., Detemmerman, C., Duterme, C., Vandenberg, O., Martin, C., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104988 · Cited by 44 · see citing works

COVID ‐19 and plasma cells: Is there long‐lived protection?*

Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 44 · see citing works

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients

Bibert, S., Guex, N., Lourenço, J., Brahier, T., Papadimitriou‐Olivgeris, M., Damonti, L., Manuel, O., Liechti, R., Götz, L., Tschopp, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666163 · Cited by 44 · see citing works

Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review

Zhu, Y., Sharma, L., & Chang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1116131 · Cited by 48 · see citing works

Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors

Wu, D., Kolesnikov, A. V., Yin, R. M., Guest, J. D., Gowthaman, R., Shmelev, A., Serdyuk, Y. V., Dianov, D. V., Efimov, G. A., Pierce, B. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27669-8 · Cited by 43 · see citing works

Bio-inspired Ag nanovilli-based sandwich-type SERS aptasensor for ultrasensitive and selective detection of 25-hydroxy vitamin D3

Kim, W., Park, J., Kim, W., Jo, S., Kim, M., Kim, C., Park, H., Bang, D., Lee, W., & Park, J. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113341 · Cited by 41 · see citing works

Obesity and COVID-19: Mechanistic Insights From Adipose Tissue

Yu, L., Zhang, X., Ye, S., Lian, H., Wang, H., & Ye, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac137 · Cited by 43 · see citing works

Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations

Cohen, L., Spiro, D. J., & Viboud, C. G. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010591 · Cited by 41 · see citing works

Impacts of COVID-19 on agriculture and food security in developing countries: potential mitigation strategies

Erinle, K. O., Ogwu, M. C., Evivie, S. E., Zaheer, M. S., Ogunyemi, S. O., & Adeniran, S. O. (2021) · CABI Reviews · doi:10.1079/pavsnnr202116016 · Cited by 40 · see citing works

Vaccines platforms and COVID-19: what you need to know

Acosta-Coley, I., Cervantes-Ceballos, L., Benítez, L. P. T., Sierra-Marquez, L., Cabarcas-Montalvo, M., Espiñeira, M. C. G., Coronell-Rodríguez, W., & Arroyo-Salgado, B. (2022) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-022-00176-4 · Cited by 40 · see citing works

Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity

Chaudhary, J. K., Yadav, R., Chaudhary, P. K., Maurya, A., Kant, N., Rugaie, O. A., Haokip, H. R., Yadav, D., Roshan, R., Prasad, R., et al. (2021) · Cells · doi:10.3390/cells10112949 · Cited by 39 · see citing works

Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination

Gonçalves, J., Juliano, A. M., Charepe, N., Alenquer, M., Athayde, D., Ferreira, F., Archer, M., Amorim, M. J., Serrano, F., & Soares, H. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100468 · Cited by 41 · see citing works

Modeling waning and boosting of COVID-19 in Canada with vaccination

Childs, L. M., Dick, D. W., Feng, Z., Heffernan, J. M., Li, J., & Röst, G. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100583 · Cited by 38 · see citing works

Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages

Lee, P., Kim, C.-U., Seo, S. H., & Kim, D. (2021) · Immune Network · doi:10.4110/in.2021.21.e4 · Cited by 39 · see citing works

GABAA-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice

Tian, J., Middleton, B., & Kaufman, D. L. (2021) · Viruses · doi:10.3390/v13060966 · Cited by 39 · see citing works

A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases

Zhou, J., Xu, W., Liu, Z., Wang, C., Xia, S., Lan, Q., Cai, Y., Su, S., Pu, J., Xing, L., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.026 · Cited by 39 · see citing works

Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells

Jensen, I. J., Li, X., McGonagill, P. W., Shan, Q., Fosdick, M. G., Tremblay, M. M., Houtman, J. C. D., Xue, H., Griffith, T. S., Peng, W., et al. (2021) · eLife · doi:10.7554/elife.70989 · Cited by 38 · see citing works

Diverse roles of long non‐coding RNAs in viral diseases

GINN, L. H., Montagna, M. L., Wu, Q., & Shi, L. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2198 · Cited by 37 · see citing works

Targets and cross-reactivity of human T cell recognition of common cold coronaviruses

Tarke, A., Zhang, Y., Methot, N., Narowski, T. M., Phillips, E. J., Mallal, S. A., Frazier, A., Filaci, G., Weiskopf, D., Dan, J. M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101088 · Cited by 36 · see citing works

Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID‐19 Vaccines

Colombani, T., Eggermont, L. J., Rogers, Z. J., McKay, L. G. A., Avena, L., Johnson, R. I., Storm, N., Griffiths, A., & Bencherif, S. (2021) · Advancement of science · doi:10.1002/advs.202100316 · Cited by 25 · see citing works

Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection

Strömer, A., Rose, R., Grobe, O., Neumann, F., Fickenscher, H., Lorentz, T., & Krumbholz, A. (2020) · Microorganisms · doi:10.3390/microorganisms8101572 · Cited by 36 · see citing works

NK cell-derived IL-10 supports host survival during sepsis

Jensen, I. J., McGonagill, P. W., Butler, N., Harty, J., Griffith, T. S., & Badovinac, V. (2021) · Journal of Immunology · doi:10.4049/jimmunol.2001131 · Cited by 38 · see citing works

High levels of soluble CD25 in COVID‐19 severity suggest a divergence between anti‐viral and pro‐inflammatory T‐cell responses

Xie, M., Yunis, J., Yao, Y., Shi, J. C., Yang, Y., Zhou, P., Liang, K., Wan, Y., Mehdi, A. M., Chen, Z., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1251 · Cited by 35 · see citing works

Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol

Quesada‐Gómez, J. M., López‐Miranda, J., Castillo, M. E., Casado‐Díaz, A., Nogués, X., Mansur, J. L., & Bouillon, R. (2022) · Nutrients · doi:10.3390/nu14132716 · Cited by 34 · see citing works

What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021

Yoo, J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e54 · Cited by 32 · see citing works

Molecular Communications in Viral Infections Research: Modeling, Experimental Data, and Future Directions

Barros, M. T., Veletić, M., Kanada, M., Pierobon, M., Vainio, S. J., Balasingham, I., & Balasubramaniam, S. (2021) · IEEE Transactions on Molecular Biological and Multi-Scale Communications · doi:10.1109/tmbmc.2021.3071780 · Cited by 35 · see citing works

Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant

Abhyankar, M. M., Mann, B. J., Sturek, J. M., Brovero, S. G., Moreau, G. B., Sengar, A., Richardson, C. M., Agah, S., Pomés, A., Kasson, P. M., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00399-0 · Cited by 32 · see citing works

SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS

Juanes‐Velasco, P., Landeira‐Viñuela, A., García‐Vaquero, M. L., Lécrevisse, Q., Herrero, R., Ferruelo, A., Góngora, R., Corrales, F. J., Rivas, J. D. L., Lorente, J. A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.732197 · Cited by 31 · see citing works

Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting

Hauser, B. M., Sangesland, M., Denis, K. S., Lam, E. C., Case, J. B., Windsor, I. W., Feldman, J. E., Caradonna, T. M., Kannegieter, T., Diamond, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110561 · Cited by 37 · see citing works

Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG

Winklmeier, S., Eisenhut, K., Taskin, D., Rübsamen, H., Gerhards, R., Schneider, C., Wratil, P. R., Stern, M., Eichhorn, P., Keppler, O. T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103659 · Cited by 30 · see citing works

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates

Cross, R. W., Prasad, A. N., Borisevich, V., Woolsey, C. B., Agans, K. N., Deer, D. J., Dobias, N. S., Geisbert, J. B., Fenton, K. A., & Geisbert, T. W. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108837 · Cited by 26 · see citing works

COVID-19 and Dentistry in 72 Questions: An Overview of the Literature

Derruau, S., Bouchet, J., Nassif, A., Baudet, A., Yasukawa, K., Lorimier, S., Prêcheur, I., Bloch‐Zupan, A., Pellat, B., Chardin, H., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040779 · Cited by 28 · see citing works

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice

Graham, J. B., Swarts, J. L., Leist, S. R., Schäfer, A., Menachery, V. D., Gralinski, L. E., Jeng, S., Miller, D. R., Mooney, M. A., McWeeney, S. K., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009287 · Cited by 26 · see citing works

Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19

Lü, Y., Liu, F., Tong, G., Qiu, F., Song, P., Wang, X., Zou, X., Wan, D., Cui, M., Xu, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00496-5 · Cited by 27 · see citing works

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity

Blasi, F., Gramegna, A., Sotgiu, G., Saderi, L., Voza, A., Aliberti, S., & Amati, F. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106355 · Cited by 26 · see citing works

Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study

Juncker, H. G., Romijn, M., Loth, V. N., Caniels, T. G., de Groot, C. J. M., Pajkrt, D., van Gils, M. J., van Goudoever, J. B., & van Keulen, B. J. (2021) · Journal of Human Lactation · doi:10.1177/08903344211030171 · Cited by 26 · see citing works

Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses

Kim, K., Hwang, I., Ku, K. B., Lee, S., Kim, S., & Kim, C. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2006.06006 · Cited by 37 · see citing works

COVID-19: a review from origin to immune responsesPreprint

Vafaeinezhad, A., Atashzar, M. R., & Baharlou, R. (2022) · doi:10.22541/au.164864737.73751616/v1

The Immune Responses against Coronavirus Infections: Friend or Foe?

Vafaeinezhad, A., Atashzar, M. R., & Baharlou, R. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000516038 · Cited by 14 · see citing works

Early Insights into Immune Responses during COVID-19

John, A. L. S., & Rathore, A. P. S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000526 · Cited by 48 · see citing works

SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines

León-Rodríguez, S. G. D., Hernández-Rico, B., Olmo-Vázquez, G. D., Cruz-Dávalos, I., & Bonifaz, L. C. (2020) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.200001911 · Cited by 8 · see citing works